SOS budesonide+formoterol improves symptom control in mild asthma


eMediNexus    29 May 2018

A study published May 17, 2018 in the New England Journal of Medicine found that while SOS budesonide (inhaled corticosteroid)-formoterol (β2-agonist) provided superior control of symptoms in patients with mild asthma as compared to as-needed terbutaline, it was inferior to budesonide maintenance therapy.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.